Genes turn into proteins. That’s the short answer, and it covers roughly 20,500 protein-coding genes in the human genome. But the full picture is more interesting: some genes produce functional RNA molecules instead of proteins, a single gene can generate thousands of different protein versions, and the journey from gene to finished product involves several transformations. Understanding this process explains how a microscopic string of DNA ultimately builds your muscles, digests your food, and determines your eye color.
The Two-Step Process: DNA to RNA to Protein
Your body converts genes into proteins through two major steps: transcription and translation. In transcription, an enzyme reads a gene’s DNA sequence and builds a matching RNA copy called messenger RNA (mRNA). This happens inside the nucleus of your cells. The enzyme moves along one strand of the DNA double helix, assembling the mRNA one building block at a time until it hits a stop signal and releases the finished strand.
Before this mRNA can leave the nucleus, it gets trimmed and packaged. Sections of the RNA that don’t carry useful instructions (called introns) are cut out, leaving only the portions needed to build the protein. The mRNA also receives a protective cap on one end and a stabilizing tail on the other, both of which prevent it from breaking down too quickly.
The mRNA then travels out of the nucleus and into the cell’s cytoplasm, where translation begins. Here, cellular machinery called ribosomes read the mRNA’s code three letters at a time. Each three-letter combination specifies one amino acid, and the ribosome chains these amino acids together like beads on a string. In human cells, this happens at an average rate of about 2.6 amino acids per second. The finished chain of amino acids is what we call a protein, though it still needs to fold into the right shape before it can do its job.
Not All Genes Make Proteins
Only about 1.5% of the human genome actually codes for proteins. That leaves an enormous amount of DNA that was once dismissed as “junk,” but scientists now know much of it is transcribed into RNA molecules that never get translated into protein. These non-coding RNAs serve their own purposes directly.
Some are well-known workhorses. Transfer RNAs carry amino acids to the ribosome during translation. Ribosomal RNAs form the structural core of the ribosome itself. Others are regulatory: microRNAs, for instance, are tiny RNA molecules that can silence specific genes by intercepting their mRNA before it gets translated. Long non-coding RNAs, which make up the largest portion of the non-coding transcriptome in mammals, help control when and where genes are turned on or off. So when a gene “turns into” something, that something isn’t always a protein. Sometimes the RNA itself is the final product.
One Gene, Many Proteins
A single gene doesn’t necessarily produce just one protein. Through a process called alternative splicing, your cells can rearrange which sections of the mRNA are kept or removed, generating multiple protein versions from the same gene. Most genes produce a handful of variants, but some take this to extremes. In fruit flies, a gene involved in brain wiring called Dscam can generate 38,016 distinct mRNA versions through alternative splicing of 95 variable segments. Another fly gene, para, combines alternative splicing with chemical editing of its RNA to potentially produce over one million different mRNA variants.
This mechanism lets organisms pack far more complexity into a limited number of genes. Rather than needing a separate gene for each protein, alternative splicing allows a single gene to serve multiple roles in different tissues or at different stages of development. It’s one reason why the human genome, with its roughly 20,500 protein-coding genes, can build a body far more complex than the gene count alone would suggest.
Proteins Still Need Finishing Touches
A freshly assembled chain of amino acids isn’t ready to work yet. It has to fold into a precise three-dimensional shape, and it often undergoes chemical modifications that fine-tune its behavior. These post-translational modifications act like switches that control where the protein goes in the cell, how active it is, and how long it lasts.
Adding a phosphate group, for example, can flip a protein from inactive to active (or vice versa) by changing its electrical charge and shape. Other modifications anchor proteins to cell membranes, tag them for destruction when they’re no longer needed, or alter how they interact with DNA and other proteins. A protein’s final function depends not just on the gene that encoded it, but on which modifications it receives after assembly.
From Gene to Trait: How It Looks in Real Life
To see how this works in practice, consider two examples: insulin and skin color.
The INS gene in your pancreatic beta cells is transcribed and translated into a precursor molecule called preproinsulin. This precursor contains a signal tag that directs it into the cell’s protein-processing compartment, where the tag is clipped off and the remaining chain folds into shape, locked by chemical bonds. Further trimming removes a middle section, leaving the two-chain insulin molecule that regulates your blood sugar. When mutations in the INS gene cause this precursor to misfold, the result is a form of diabetes.
Eye and skin color involve a different kind of gene-to-trait path. The MC1R gene produces a receptor protein on the surface of pigment-producing cells. When this receptor is activated, it triggers a signaling cascade that promotes production of brown-black pigment called eumelanin. Certain variants of MC1R disrupt this signaling, shifting pigment production toward a red-yellow type instead. This is why those variants are strongly associated with lighter skin, red hair, and freckling, particularly in European populations. Another gene, OCA2, influences the acidity inside the compartments where pigment is made and stored. A specific variant near OCA2 dials down its activity, reducing melanin content and producing blue eyes. In both cases, the gene’s protein product doesn’t directly “become” a visible trait. It sets off a chain of biochemical events that ultimately determines how much pigment your cells produce and what type it is.
The Big Picture
Genes are instructions, not finished products. What they turn into depends on the type of gene: most become proteins through the transcription-translation pipeline, while others become functional RNA molecules that regulate cellular activity. The proteins themselves are further shaped by folding and chemical modifications before they’re ready to work. And because of alternative splicing, the number of functional molecules your genome can produce far exceeds the number of genes it contains. The path from gene to final product is less like flipping a switch and more like a multi-stage assembly line, with quality controls and customization options at every step.